BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17078635)

  • 1. Quantitative structure-activity (affinity) relationship (QSAR) study on protonation and cationization of alpha-amino acids.
    Siu FM; Che CM
    J Phys Chem A; 2006 Nov; 110(44):12348-54. PubMed ID: 17078635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure-property relationship estimation of cation binding affinity of the common amino acids.
    Jover J; Bosque R; Sales J
    J Phys Chem A; 2009 Apr; 113(15):3703-8. PubMed ID: 19298068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico quantitative prediction of peptides binding affinity to human MHC molecule: an intuitive quantitative structure-activity relationship approach.
    Tian F; Yang L; Lv F; Yang Q; Zhou P
    Amino Acids; 2009 Mar; 36(3):535-54. PubMed ID: 18575802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the binding affinity of the common amino acids with different metal cations.
    Jover J; Bosque R; Sales J
    Dalton Trans; 2008 Dec; (45):6441-53. PubMed ID: 19002332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New descriptors of amino acids and their application to peptide QSAR study.
    Lin ZH; Long HX; Bo Z; Wang YQ; Wu YZ
    Peptides; 2008 Oct; 29(10):1798-805. PubMed ID: 18606203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of the aqueous solubility of benzylamine salts using QSPR model.
    Tantishaiyakul V
    J Pharm Biomed Anal; 2005 Feb; 37(2):411-5. PubMed ID: 15708687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New 3D amino acid structure descriptors and its application to the polypeptide QSAR].
    Ding JJ; Ding XQ; Zhao LF; Chen JS
    Yao Xue Xue Bao; 2005 Apr; 40(4):340-6. PubMed ID: 16011263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLR-ANN and RTO approach to mu-opioid receptor-binding affinity. Pooling data from different sources.
    Ramírez-Galicia G; Garduño-Juárez R; Deeb O; Hemmateenejad B
    Chem Biol Drug Des; 2008 Mar; 71(3):260-70. PubMed ID: 18248352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
    Nandi S; Vracko M; Bagchi MC
    Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of QSAR models to predict and interpret the biological activity of artemisinin analogues.
    Guha R; Jurs PC
    J Chem Inf Comput Sci; 2004; 44(4):1440-9. PubMed ID: 15272852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new SVRDF 3D-descriptor of amino acids and its application to peptide quantitative structure activity relationship].
    Tong JB; Zhang SW; Cheng SL; Li GX
    Yao Xue Xue Bao; 2007 Jan; 42(1):40-6. PubMed ID: 17520805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor analysis scales of generalized amino acid information as applied in predicting interactions between the human amphiphysin-1 SH3 domains and their peptide ligands.
    Liang G; Chen G; Niu W; Li Z
    Chem Biol Drug Des; 2008 Apr; 71(4):345-51. PubMed ID: 18318694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR study of imidazoline antihypertensive drugs.
    Nikolic K; Filipic S; Agbaba D
    Bioorg Med Chem; 2008 Aug; 16(15):7134-40. PubMed ID: 18621536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative QSAR modeling of CCR5 receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas.
    Thomas Leonard J; Roy K
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4467-74. PubMed ID: 16806923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high dimensional QSAR study on the aldose reductase inhibitory activity of some flavones: topological descriptors in modeling the activity.
    Prabhakar YS; Gupta MK; Roy N; Venkateswarlu Y
    J Chem Inf Model; 2006; 46(1):86-92. PubMed ID: 16426043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Support vector machine for SAR/QSAR of phenethyl-amines.
    Niu B; Lu WC; Yang SS; Cai YD; Li GZ
    Acta Pharmacol Sin; 2007 Jul; 28(7):1075-86. PubMed ID: 17588345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation.
    Votano JR; Parham M; Hall LM; Hall LH; Kier LB; Oloff S; Tropsha A
    J Med Chem; 2006 Nov; 49(24):7169-81. PubMed ID: 17125269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust cross-validation of linear regression QSAR models.
    Konovalov DA; Llewellyn LE; Vander Heyden Y; Coomans D
    J Chem Inf Model; 2008 Oct; 48(10):2081-94. PubMed ID: 18826208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel QSAR model for prediction of apoptosis-inducing activity of 4-aryl-4-H-chromenes based on support vector machine.
    Fatemi MH; Gharaghani S
    Bioorg Med Chem; 2007 Dec; 15(24):7746-54. PubMed ID: 17870538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.